Background Malnutrition influences prognosis in patients with heart failure, but current nutritional evaluation methods are ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback